Thrombospondin 2 is a novel biomarker of essential hypertension and associated with nocturnal Na(+) excretion and insulin resistance.
Zhou X, Zhang L, Lin X, Chen X, Liu H, Yuan X, Zhao Q, Wang W, Lei X, Jose PA, et al. Clin Exp Hypertens. 2023 Dec 31; 45(1):2276029. Epub 2023 Nov 9.